BIPROGY (8056) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Oct, 2026Executive summary
FY March 2025 revenue rose 9.2% to ¥404,010m; operating profit increased 17.4% to ¥39,066m, with operating margin up 0.7pt to 9.7%.
Profit attributable to owners of parent grew 6.8% to ¥26,965m; adjusted operating profit rose 13.6% to ¥38,420m.
Orders grew 4.6% to ¥404.0bn; total backlog was ¥289.8bn, with next-FY backlog up 5.9% to ¥149.1bn.
Management Policies (2024–2026) focus on sustainable business portfolios and a stronger business platform, with growth areas including DX, banking, retail automation, energy, mobility and global expansion.
Financial highlights
Q4 revenue increased 12.1% YoY to ¥124.7bn; operating profit rose 51.8% to ¥13.9bn, with margin up 2.9pt to 11.1%.
FY revenue growth included services +¥20.2bn and product sales +¥13.7bn; adjusted operating profit rose ¥4.6bn, including ¥4.7bn growth from services, partly offset by higher SG&A.
Gross profit increased 8.9% to ¥105.8bn; SG&A rose 6.4% to ¥67.4bn, including higher personnel and internal-system renewal expenses.
Total assets reached ¥330,876m; period-end cash was ¥64,801m, up ¥5,538m YoY.
Operating cash flow was ¥44,916m, investing cash flow -¥8,926m and financing cash flow -¥30,613m; basic EPS rose to ¥272.65 from ¥251.15.
Outlook and guidance
FY March 2026 forecast: revenue ¥420.0bn (+4.0%), operating profit ¥42.6bn (+9.0%), net profit ¥29.0bn (+7.5%) and operating margin 10.1%.
Adjusted operating profit is forecast at ¥42.0bn (+9.3%) and adjusted operating margin at 10.0%; services profitability is expected to improve as services and product sales grow.
FY March 2027 revenue target raised to ¥440.0bn from ¥420.0bn; ROE target raised to at least 17.0% from 15.0%, while adjusted operating margin target remains 11.0%.
Latest events from BIPROGY
- Q1 operating profit rose 22% as revenue, orders, and backlog grew.8056
Q1 2024 - H1 revenue rose 11.8% and operating profit 21.9%; FY guidance stayed unchanged.8056
Q2 2024 - Strong DX demand lifted FYMar2024 results; growth investment supports FYMar2025 expansion.8056
Q4 2024 - 9M revenue and operating profit grew; full-year forecasts and dividends rose.8056
Q3 2024 - Deferred product sales cut Q1 profit, while orders surged and FY2027 guidance stayed unchanged.8056
Q1 2027 - Q1 revenue and operating profit grew, with full-year guidance unchanged.8056
Q1 2025 - Revenue and operating profit rose, but net profit declined; full-year guidance was unchanged.8056
Q2 2025 - Revenue and orders grew, lifting the FY revenue forecast despite lower net profit.8056
Q3 2025 - Q1 revenue and profit grew; full-year guidance remains unchanged.8056
Q1 2026